We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

CHRONIC INVESTOR BLOG

Our light-hearted take on the world of investing

Yesterday

The rate of UK GDP growth slowed during the first quarter of the year, on the back of aneamic production and construction.   Continue reading

Death by a thousand cuts at BHS. Each provides a lesson

Learning the lessons of the retailer's downfall  Continue reading

AstraZeneca launches largest ever genome sequencing project

The move may silence those who have criticised the pharma company's level of innovation  Continue reading

Tuesday,26 April 2016

The battle for the premium pub-goer intensifies as Upham eyes market entry

The Home Counties-focused pub chain is eyeing a listing on London's junior market and will be targeting the popular premium end of the market  Continue reading

Oiling the wheels at BP

The AGM protest vote raises questions for BP – and for its shareholders  Continue reading

US shale production is undergoing a painful contraction. What will this mean for oil supply and prices?   Continue reading

Monday,25 April 2016

There's been an endless stream of claims and counter-claims linked to the market effects of Brexit, but the UK's persistent balance of payments deficit surely points to an overvalued pound.  Continue reading

Thursday,21 April 2016

How the components of a birthday tea party have increased in price over the past 90 years  Continue reading

Headline inflation in the UK picked up in March, but that might not be the true picture.  Continue reading

Wednesday,20 April 2016

Why the IPO market isn’t all that bad

Will FCA reform encourage businesses to come to market?  Continue reading

Most read posts this week

    Register today and get...

    Register today and get...
    Please note terms & conditions apply